Precision BioSciences, Inc. (DTIL) earnings
DTIL earnings moved a median of -0.55% by the close. Quarterly and annual DTIL reports and results, each read against the price at its own news timestamp. Back to the DTIL overview →
30 measured DTIL earnings events.
Where these DTIL earnings landedvs 30 measured DTIL earnings reactions
| Middle 50% of DTIL earnings reactions | -4.35% to +4.10% |
|---|---|
| Median reaction (to close) | -0.55% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 DTIL earnings events with a measured close landed between -4.35% and +4.10%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PRECISION BIOSCIENCES For: Jun 30 | SEC filing · Form 10-Q | +6.50% | +6.00% | |
| Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +6.50% | +6.00% | |
| Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | -1.41% | -1.27% | |
| Form 10-Q PRECISION BIOSCIENCES For: Mar 31 | SEC filing · Form 10-Q | +0.71% | +5.38% | |
| Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | +0.71% | +5.38% | |
| Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026 | Press release | +1.38% | +3.47% | |
| Form 10-K PRECISION BIOSCIENCES For: Dec 31 | SEC filing · Form 10-K | -4.00% | +0.71% | |
| Form 10-Q PRECISION BIOSCIENCES For: Sep 30 | SEC filing · Form 10-Q | -2.17% | +14.11% | |
| Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -2.17% | +14.11% | |
| Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 | Press release | -0.44% | -5.56% | |
| Form 10-Q PRECISION BIOSCIENCES For: Jun 30 | SEC filing · Form 10-Q | +1.23% | +0.00% | |
| Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +1.23% | +0.00% | |
| Precision BioSciences to Report Second Quarter 2025 Results on August 7, 2025 | Press release | +2.64% | +4.31% | |
| Form 10-Q PRECISION BIOSCIENCES For: Mar 31 | SEC filing · Form 10-Q | +0.44% | -5.01% | |
| Precision BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +0.44% | -5.01% | |
| Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025 | Press release | +1.37% | +0.78% | |
| Form 10-K PRECISION BIOSCIENCES For: Dec 31 | SEC filing · Form 10-K | -1.38% | -10.65% | |
| Form 10-Q PRECISION BIOSCIENCES For: Sep 30 | SEC filing · Form 10-Q | +1.41% | -2.36% | |
| Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +1.41% | -2.36% | |
| Precision BioSciences to Report Third Quarter Results on November 4, 2024 | Press release | +0.00% | -1.09% | |
| Form 10-Q PRECISION BIOSCIENCES For: Jun 30 | SEC filing · Form 10-Q | +0.78% | -6.54% | |
| Precision BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +0.78% | -6.54% | |
| Precision BioSciences to Report Second Quarter Results on August 1, 2024 | Press release | +0.95% | -2.95% | |
| Form 10-Q PRECISION BIOSCIENCES For: Mar 31 | SEC filing · Form 10-Q | -2.78% | -4.56% | |
| Precision BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -2.78% | -4.56% | |
| Precision BioSciences to Report First Quarter Results on May 13, 2024 | Press release | -1.54% | +1.99% | |
| Form 10-K PRECISION BIOSCIENCES For: Dec 31 | SEC filing · Form 10-K | -6.45% | +1.41% | |
| Form 10-Q PRECISION BIOSCIENCES For: Sep 30 | SEC filing · Form 10-Q | +1.21% | -3.73% | |
| Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +1.21% | -3.73% | |
| Precision BioSciences to Report Third Quarter Results on November 7, 2023 | Press release | -2.67% | +21.09% |
Keep exploring
More DTIL: analyst actions → · SEC filings → · DTIL overview →